Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Fosfomycin tromethamine, white or almost white crystalline powder; odorless, taste salty; Very soluble in water, dissolved in methanol, very slightly soluble in ethanol, insoluble in chloroform.
Mainly for the treatment of urinary tract infections such as cystitis, urethritis.
Market Analysis and Insights: Global Fosfomycin Trometamol Market
Due to the COVID-19 pandemic, the global Fosfomycin Trometamol market size is estimated to be worth US$ 32 million in 2021 and is forecast to a readjusted size of US$ 32 million by 2028 with a CAGR of 3.0% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Fosfomycin Trometamol global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
Global Fosfomycin Trometamol key players include Zambon, Northesat Pharm, Hunan Huana Pharmaceuticals, etc. Global top three manufacturers hold a share over 60%.
China is the largest market, with a share over 60%, followed by Europe, with a share over 30 percent.
In terms of product, Fosfomycin Tromethamine Granules is the largest segment, with a share over 55%. And in terms of application, the largest application is Common Urinary Tract Infection, followed by Postoperative Urinary Tract Infection, Preoperative Prevention of Urinary Tract Infection, etc.
Global Fosfomycin Trometamol Scope and Market Size
The global Fosfomycin Trometamol market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Fosfomycin Trometamol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Segment by Type
Fosfomycin Tromethamine Granules
Fosfomycin Tromethamine Powder
Segment by Application
Common Urinary Tract Infection
Postoperative Urinary Tract Infection
Preoperative Prevention of Urinary Tract Infection
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Zambon
Northesat Pharm
Hunan Huana Pharmaceuticals
Xunda Pharma
FarmaSino Pharmaceutical
Guilin Hwasun
Mainly for the treatment of urinary tract infections such as cystitis, urethritis.
Market Analysis and Insights: Global Fosfomycin Trometamol Market
Due to the COVID-19 pandemic, the global Fosfomycin Trometamol market size is estimated to be worth US$ 32 million in 2021 and is forecast to a readjusted size of US$ 32 million by 2028 with a CAGR of 3.0% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Fosfomycin Trometamol global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
Global Fosfomycin Trometamol key players include Zambon, Northesat Pharm, Hunan Huana Pharmaceuticals, etc. Global top three manufacturers hold a share over 60%.
China is the largest market, with a share over 60%, followed by Europe, with a share over 30 percent.
In terms of product, Fosfomycin Tromethamine Granules is the largest segment, with a share over 55%. And in terms of application, the largest application is Common Urinary Tract Infection, followed by Postoperative Urinary Tract Infection, Preoperative Prevention of Urinary Tract Infection, etc.
Global Fosfomycin Trometamol Scope and Market Size
The global Fosfomycin Trometamol market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Fosfomycin Trometamol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Segment by Type
Fosfomycin Tromethamine Granules
Fosfomycin Tromethamine Powder
Segment by Application
Common Urinary Tract Infection
Postoperative Urinary Tract Infection
Preoperative Prevention of Urinary Tract Infection
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Zambon
Northesat Pharm
Hunan Huana Pharmaceuticals
Xunda Pharma
FarmaSino Pharmaceutical
Guilin Hwasun
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
